CRISPR Therapeutics AG (NASDAQ:CRSP)
| 45.21 Delayed Data As of Mar 31 |  +1.05 / +2.38%Today’s Change | 38.94 Today|||52-Week Range 86.95 | +11.22% Year-to-Date |
Latest CRSP News | Press Releases
Today’s Trading
| Previous close | 44.16 |
| Today’s open | 44.35 |
| Day’s range | 44.10 - 45.69 |
| Volume | 150,651 |
| Average volume (3 months) | 1,057,306 |
| Market cap | $3.6B |
Data as of 4:00pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | -268.18% |
| Earnings growth (this year) | +19.34% |
| Earnings growth (next 5 years) | -38.91% |
| Revenue growth (last year) | -99.87% |
| P/E ratio | NM |
| Price/Sales | 2,638.06 |
| Price/Book | 1.89 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NTLAIntellia Therapeutic... | +1.22 | +3.39% |
| ZLABZai Lab Ltd | -0.44 | -1.30% |
| DNLIDenali Therapeutics ... | +1.14 | +5.20% |
| ---- |
Data as of 4:00pm ET, 03/31/2023
Financials
| Next reporting date | May 9, 2023 |
| EPS forecast (this quarter) | -$1.79 |
| Annual revenue (last year) | $1.2M |
| Annual profit (last year) | -$650.2M |
| Net profit margin | -54,271.70% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Zug, Zug |
Forecasts
